American Cryostem (American Cryostem) Short-Term Debt & Capital Lease Obligation : $1.02 Mil (As of Jun. 2022)

View and export this data going back to 2010. Start your Free Trial

What is American Cryostem Short-Term Debt & Capital Lease Obligation?

Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. American Cryostem's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2022 was $1.02 Mil.

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. American Cryostem's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2022 was $0.15 Mil.

American Cryostem Short-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for American Cryostem's Short-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Cryostem Short-Term Debt & Capital Lease Obligation Chart

American Cryostem Annual Data

Trend

Sep12

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Short-Term Debt & Capital Lease Obligation

Get a 7-Day Free Trial

1.09

0.58

0.66

0.84

0.86

American Cryostem Quarterly Data
	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22
Short-Term Debt & Capital Lease Obligation	Get a 7-Day Free Trial															0.82	0.86	0.99	1.02	1.02

American Cryostem Short-Term Debt & Capital Lease Obligation Calculation

This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.

In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

American Cryostem Short-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of American Cryostem's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

American Cryostem (American Cryostem) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Cryostem Corp (OTCPK:CRYO) » Definitions » Short-Term Debt & Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Meridian Road, Suite 5, Eatontown, NJ, USA, 07724

Website

http://www.americancryostem.com

American Cryostem Corp is a biotechnology company which standardizes adipose tissue-derived technologies (Adult Stem Cells) for the fields of Regenerative and Personalized Medicine. The company acts as an innovator of adipose tissue and stem cell platform technologies. It provides the clinical grade, adipose tissue and adult stem cell collection, processing, and cryo-preservation technology, providing first-in-class cellular therapy products and services for patients, physicians and researchers based on the transformative science of Regenerative and Personalized Medicine.

Executives

John S Arnone	director, officer: Chairman	111 GREAT NECK RD, GREAT NECK NY 11021
Anthony Francis Dudzinski	director, officer: COO	188 EAST BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Acs Global, Inc.	10 percent owner	188 E. BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Christopher Joseph Neill	10 percent owner	188 EAST BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Hector Medina	director, 10 percent owner, officer: President and Director	1206 STAGECOACH TRAIL LOOP, CHULA VISTA CA 91915